Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 51 entries
Sorted by: Best Match Show Resources per page
Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt.

Cardiovascular radiation medicine

Dvorák J, Hůlek P, Raupach J, Vanásek T, Petera J, Krajina A, Vanásek J, Zoul Z, Odrázka K, Lojík M, Masková J, Safka V, Vodnansky P, Fridrich J.
PMID: 11068248
Cardiovasc Radiat Med. 2001 Jan 01;2(1):3-6.

Purpose: To evaluate the technical feasibility and efficacy of endovascular brachytherapy with Iridium-192 in the prevention of restenosis caused by neointimal hyperplasia of transjugular intrahepatic portosystemic shunt (TIPS).Materials and Methods: The endovascular brachytherapy with high dose rate automatic afterloading...

Cite
Dvorák J, Hůlek P, Raupach J, et al. Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt. Cardiovasc Radiat Med. 2001;2(1):3-6
Dvorák, J., Hůlek, P., Raupach, J., Vanásek, T., Petera, J., Krajina, A., Vanásek, J., Zoul, Z., Odrázka, K., Lojík, M., Masková, J., Safka, V., Vodnansky, P., & Fridrich, J. (2001). Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt. Cardiovascular radiation medicine, 2(1), 3-6.
Dvorák, et al. "Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt." Cardiovascular radiation medicine vol. 2,1 (2001): 3-6.
Dvorák J, Hůlek P, Raupach J, Vanásek T, Petera J, Krajina A, Vanásek J, Zoul Z, Odrázka K, Lojík M, Masková J, Safka V, Vodnansky P, Fridrich J. Endovascular brachytherapy of transjugular intrahepatic portosystemic shunt. Cardiovasc Radiat Med. 2001 Jan 01;2(1):3-6. PMID: 11068248.
Copy Download .nbib Format: NLM
Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries.

Cardiovascular radiation medicine

Waksman R, Bhargava B, Saucedo JF, Chan RC, Tio FO, Vodovotz Y, Verin V.
PMID: 11068250
Cardiovasc Radiat Med. 2001 Jan 01;2(1):11-17.

Background: Intracoronary radiation (IR) studies have shown reduction of neointima formation (NF). Extrapolation of animal studies with beta-radiation to clinical trials have shown variable results, which may be related to dosimetry, centering issues, and/or shielding of beta-rays by the...

Cite
Waksman R, Bhargava B, Saucedo JF, et al. Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries. Cardiovasc Radiat Med. 2001;2(1):11-17
Waksman, R., Bhargava, B., Saucedo, J. F., Chan, R. C., Tio, F. O., Vodovotz, Y., & Verin, V. (2001). Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries. Cardiovascular radiation medicine, 2(1), 11-17.
Waksman, et al. "Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries." Cardiovascular radiation medicine vol. 2,1 (2001): 11-17.
Waksman R, Bhargava B, Saucedo JF, Chan RC, Tio FO, Vodovotz Y, Verin V. Yttrium-90 delivered via a centering catheter and afterloader, given both before and after stent implantation, inhibits neointima formation in porcine coronary arteries. Cardiovasc Radiat Med. 2001 Jan 01;2(1):11-17. PMID: 11068250.
Copy Download .nbib Format: NLM
Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis.

Cardiovascular radiation medicine

Fareh J, Martel R, Leclerc G.
PMID: 11068257
Cardiovasc Radiat Med. 2001 Jan 01;2(1):51. doi: 10.1016/s1522-1865(00)00046-9.

No abstract available.

Cite
Fareh J, Martel R, Leclerc G. Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis. Cardiovasc Radiat Med. 2001;2(1):51doi: 10.1016/s1522-1865(00)00046-9.
Fareh, J., Martel, R., & Leclerc, G. (2001). Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis. Cardiovascular radiation medicine, 2(1), 51. https://doi.org/10.1016/s1522-1865(00)00046-9
Fareh, et al. "Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis." Cardiovascular radiation medicine vol. 2,1 (2001): 51. doi: https://doi.org/10.1016/s1522-1865(00)00046-9
Fareh J, Martel R, Leclerc G. Feasibility, safety and dosimetry of intramural administration of 32P-oligonucleotide-mediating beta-particle delivery to prevent restenosis. Cardiovasc Radiat Med. 2001 Jan 01;2(1):51. doi: 10.1016/s1522-1865(00)00046-9. PMID: 11068257.
Copy Download .nbib Format: NLM
Influence of metal-artery ratio on the dose reduction due to stent.

Cardiovascular radiation medicine

Fan P, Chiu-Tsao S, Patel N, Shih JA, Ravi K, Sherman W, Tsao H, Pisch J, Harrison LB.
PMID: 11068260
Cardiovasc Radiat Med. 2001 Jan 01;2(1):52. doi: 10.1016/s1522-1865(00)00050-0.

No abstract available.

Cite
Fan P, Chiu-Tsao S, Patel N, et al. Influence of metal-artery ratio on the dose reduction due to stent. Cardiovasc Radiat Med. 2001;2(1):52doi: 10.1016/s1522-1865(00)00050-0.
Fan, P., Chiu-Tsao, S., Patel, N., Shih, J. A., Ravi, K., Sherman, W., Tsao, H., Pisch, J., & Harrison, L. B. (2001). Influence of metal-artery ratio on the dose reduction due to stent. Cardiovascular radiation medicine, 2(1), 52. https://doi.org/10.1016/s1522-1865(00)00050-0
Fan, et al. "Influence of metal-artery ratio on the dose reduction due to stent." Cardiovascular radiation medicine vol. 2,1 (2001): 52. doi: https://doi.org/10.1016/s1522-1865(00)00050-0
Fan P, Chiu-Tsao S, Patel N, Shih JA, Ravi K, Sherman W, Tsao H, Pisch J, Harrison LB. Influence of metal-artery ratio on the dose reduction due to stent. Cardiovasc Radiat Med. 2001 Jan 01;2(1):52. doi: 10.1016/s1522-1865(00)00050-0. PMID: 11068260.
Copy Download .nbib Format: NLM
Two-year QCA follow-up after post-PTCA beta-radiation in de novo lesions.

Cardiovascular radiation medicine

Meerkin D, Joyal M, Lespérance J, Bonan R.
PMID: 11068261
Cardiovasc Radiat Med. 2001 Jan 01;2(1):52. doi: 10.1016/s1522-1865(00)00049-4.

No abstract available.

Cite
Meerkin D, Joyal M, Lespérance J, et al. Two-year QCA follow-up after post-PTCA beta-radiation in de novo lesions. Cardiovasc Radiat Med. 2001;2(1):52doi: 10.1016/s1522-1865(00)00049-4.
Meerkin, D., Joyal, M., Lespérance, J., & Bonan, R. (2001). Two-year QCA follow-up after post-PTCA beta-radiation in de novo lesions. Cardiovascular radiation medicine, 2(1), 52. https://doi.org/10.1016/s1522-1865(00)00049-4
Meerkin, et al. "Two-year QCA follow-up after post-PTCA beta-radiation in de novo lesions." Cardiovascular radiation medicine vol. 2,1 (2001): 52. doi: https://doi.org/10.1016/s1522-1865(00)00049-4
Meerkin D, Joyal M, Lespérance J, Bonan R. Two-year QCA follow-up after post-PTCA beta-radiation in de novo lesions. Cardiovasc Radiat Med. 2001 Jan 01;2(1):52. doi: 10.1016/s1522-1865(00)00049-4. PMID: 11068261.
Copy Download .nbib Format: NLM
beta-Irradiation for in-stent restenosis.

Cardiovascular radiation medicine

Latchem D, Urban P, Goy J, Coucke P, Eeckhout E.
PMID: 11068266
Cardiovasc Radiat Med. 2001 Jan 01;2(1):54. doi: 10.1016/s1522-1865(00)00055-x.

No abstract available.

Cite
Latchem D, Urban P, Goy J, et al. beta-Irradiation for in-stent restenosis. Cardiovasc Radiat Med. 2001;2(1):54doi: 10.1016/s1522-1865(00)00055-x.
Latchem, D., Urban, P., Goy, J., Coucke, P., & Eeckhout, E. (2001). beta-Irradiation for in-stent restenosis. Cardiovascular radiation medicine, 2(1), 54. https://doi.org/10.1016/s1522-1865(00)00055-x
Latchem, et al. "beta-Irradiation for in-stent restenosis." Cardiovascular radiation medicine vol. 2,1 (2001): 54. doi: https://doi.org/10.1016/s1522-1865(00)00055-x
Latchem D, Urban P, Goy J, Coucke P, Eeckhout E. beta-Irradiation for in-stent restenosis. Cardiovasc Radiat Med. 2001 Jan 01;2(1):54. doi: 10.1016/s1522-1865(00)00055-x. PMID: 11068266.
Copy Download .nbib Format: NLM
High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty.

Cardiovascular radiation medicine

Tepe G, Dinkelborg LM, Muschik P, Dietrich T, Claussen CD, Noll B, Wiskirchen J, Duda SH.
PMID: 11068267
Cardiovasc Radiat Med. 2001 Jan 01;2(1):54. doi: 10.1016/s1522-1865(00)00054-8.

No abstract available.

Cite
Tepe G, Dinkelborg LM, Muschik P, et al. High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty. Cardiovasc Radiat Med. 2001;2(1):54doi: 10.1016/s1522-1865(00)00054-8.
Tepe, G., Dinkelborg, L. M., Muschik, P., Dietrich, T., Claussen, C. D., Noll, B., Wiskirchen, J., & Duda, S. H. (2001). High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty. Cardiovascular radiation medicine, 2(1), 54. https://doi.org/10.1016/s1522-1865(00)00054-8
Tepe, et al. "High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty." Cardiovascular radiation medicine vol. 2,1 (2001): 54. doi: https://doi.org/10.1016/s1522-1865(00)00054-8
Tepe G, Dinkelborg LM, Muschik P, Dietrich T, Claussen CD, Noll B, Wiskirchen J, Duda SH. High-dose Re-186 stent implantation for prevention of neointimal proliferation after balloon angioplasty. Cardiovasc Radiat Med. 2001 Jan 01;2(1):54. doi: 10.1016/s1522-1865(00)00054-8. PMID: 11068267.
Copy Download .nbib Format: NLM
Neointima formation inhibited, but healing incomplete 12 months after deployment of high-dose 32P beta-emitting stents.

Cardiovascular radiation medicine

Shroff S, Farb A, John M, Virmani R.
PMID: 11068272
Cardiovasc Radiat Med. 2001 Jan 01;2(1):56. doi: 10.1016/s1522-1865(00)00061-5.

No abstract available.

Cite
Shroff S, Farb A, John M, et al. Neointima formation inhibited, but healing incomplete 12 months after deployment of high-dose 32P beta-emitting stents. Cardiovasc Radiat Med. 2001;2(1):56doi: 10.1016/s1522-1865(00)00061-5.
Shroff, S., Farb, A., John, M., & Virmani, R. (2001). Neointima formation inhibited, but healing incomplete 12 months after deployment of high-dose 32P beta-emitting stents. Cardiovascular radiation medicine, 2(1), 56. https://doi.org/10.1016/s1522-1865(00)00061-5
Shroff, et al. "Neointima formation inhibited, but healing incomplete 12 months after deployment of high-dose 32P beta-emitting stents." Cardiovascular radiation medicine vol. 2,1 (2001): 56. doi: https://doi.org/10.1016/s1522-1865(00)00061-5
Shroff S, Farb A, John M, Virmani R. Neointima formation inhibited, but healing incomplete 12 months after deployment of high-dose 32P beta-emitting stents. Cardiovasc Radiat Med. 2001 Jan 01;2(1):56. doi: 10.1016/s1522-1865(00)00061-5. PMID: 11068272.
Copy Download .nbib Format: NLM
Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study.

Cardiovascular radiation medicine

Ahmed JM, Waksman R, Weissman NJ, Harrington D, Pappas C, Hong MK, Satler LF, Caños D, Kent KM, Pichard AD, Mintz GS.
PMID: 11068279
Cardiovasc Radiat Med. 2001 Jan 01;2(1):58.

No abstract available.

Cite
Ahmed JM, Waksman R, Weissman NJ, et al. Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study. Cardiovasc Radiat Med. 2001;2(1):58
Ahmed, J. M., Waksman, R., Weissman, N. J., Harrington, D., Pappas, C., Hong, M. K., Satler, L. F., Caños, D., Kent, K. M., Pichard, A. D., & Mintz, G. S. (2001). Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study. Cardiovascular radiation medicine, 2(1), 58.
Ahmed, et al. "Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study." Cardiovascular radiation medicine vol. 2,1 (2001): 58.
Ahmed JM, Waksman R, Weissman NJ, Harrington D, Pappas C, Hong MK, Satler LF, Caños D, Kent KM, Pichard AD, Mintz GS. Mechanism of edge recurrence following brachytherapy treatment of in-stent restenosis: a serial intravascular ultrasound study. Cardiovasc Radiat Med. 2001 Jan 01;2(1):58. PMID: 11068279.
Copy Download .nbib Format: NLM
T-cell infiltration and apoptosis following intracoronary radiation for the prevention of restenosis in porcine coronaries.

Cardiovascular radiation medicine

Vodovotz Y, Kollum M, Chan R, Waksman R.
PMID: 11068280
Cardiovasc Radiat Med. 2001 Jan 01;2(1):58-59. doi: 10.1016/s1522-1865(00)00070-6.

No abstract available.

Cite
Vodovotz Y, Kollum M, Chan R, et al. T-cell infiltration and apoptosis following intracoronary radiation for the prevention of restenosis in porcine coronaries. Cardiovasc Radiat Med. 2001;2(1):58-59doi: 10.1016/s1522-1865(00)00070-6.
Vodovotz, Y., Kollum, M., Chan, R., & Waksman, R. (2001). T-cell infiltration and apoptosis following intracoronary radiation for the prevention of restenosis in porcine coronaries. Cardiovascular radiation medicine, 2(1), 58-59. https://doi.org/10.1016/s1522-1865(00)00070-6
Vodovotz, et al. "T-cell infiltration and apoptosis following intracoronary radiation for the prevention of restenosis in porcine coronaries." Cardiovascular radiation medicine vol. 2,1 (2001): 58-59. doi: https://doi.org/10.1016/s1522-1865(00)00070-6
Vodovotz Y, Kollum M, Chan R, Waksman R. T-cell infiltration and apoptosis following intracoronary radiation for the prevention of restenosis in porcine coronaries. Cardiovasc Radiat Med. 2001 Jan 01;2(1):58-59. doi: 10.1016/s1522-1865(00)00070-6. PMID: 11068280.
Copy Download .nbib Format: NLM
The edge stenosis after intracoronary radiation therapy: is it all a "geographical miss"?.

Cardiovascular radiation medicine

Kim H, Cottin Y, Kollum M, Lansky AJ, Chan RC, Mehran R, Bhargava B, Waksman R.
PMID: 11068282
Cardiovasc Radiat Med. 2001 Jan 01;2(1):59. doi: 10.1016/s1522-1865(00)00072-x.

No abstract available.

Cite
Kim H, Cottin Y, Kollum M, et al. The edge stenosis after intracoronary radiation therapy: is it all a "geographical miss"?. Cardiovasc Radiat Med. 2001;2(1):59doi: 10.1016/s1522-1865(00)00072-x.
Kim, H., Cottin, Y., Kollum, M., Lansky, A. J., Chan, R. C., Mehran, R., Bhargava, B., & Waksman, R. (2001). The edge stenosis after intracoronary radiation therapy: is it all a "geographical miss"?. Cardiovascular radiation medicine, 2(1), 59. https://doi.org/10.1016/s1522-1865(00)00072-x
Kim, et al. "The edge stenosis after intracoronary radiation therapy: is it all a "geographical miss"?." Cardiovascular radiation medicine vol. 2,1 (2001): 59. doi: https://doi.org/10.1016/s1522-1865(00)00072-x
Kim H, Cottin Y, Kollum M, Lansky AJ, Chan RC, Mehran R, Bhargava B, Waksman R. The edge stenosis after intracoronary radiation therapy: is it all a "geographical miss"?. Cardiovasc Radiat Med. 2001 Jan 01;2(1):59. doi: 10.1016/s1522-1865(00)00072-x. PMID: 11068282.
Copy Download .nbib Format: NLM
Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy.

International journal of oncology

Gridley D, Slater J, Yonemoto L, Miller D, Rossi C, Archambeau J, Andres M, Oey M.
PMID: 21544347
Int J Oncol. 1996 Jan;8(1):175-81. doi: 10.3892/ijo.8.1.175.

The mechanisms responsible for normal tissue late effects following radiotherapy are largely unknown and currently no method for predicting such risks is available. Abnormal levels of cytokine production induced by radiation has been suggested as a contributing factor by...

Cite
Gridley D, Slater J, Yonemoto L, et al. Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy. Int J Oncol. 1996;8(1):175-81doi: 10.3892/ijo.8.1.175.
Gridley, D., Slater, J., Yonemoto, L., Miller, D., Rossi, C., Archambeau, J., Andres, M., & Oey, M. (1996). Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy. International journal of oncology, 8(1), 175-81. https://doi.org/10.3892/ijo.8.1.175
Gridley, D, et al. "Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy." International journal of oncology vol. 8,1 (1996): 175-81. doi: https://doi.org/10.3892/ijo.8.1.175
Gridley D, Slater J, Yonemoto L, Miller D, Rossi C, Archambeau J, Andres M, Oey M. Pilot study of cytokine profiles in prostate cancer patients undergoing proton or conventional radiotherapy. Int J Oncol. 1996 Jan;8(1):175-81. doi: 10.3892/ijo.8.1.175. PMID: 21544347.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 51 entries